540 related articles for article (PubMed ID: 15516806)
1. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
2. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
Ohtsuki S
Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
Ohtsuki S; Hori S; Terasaki T
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
[TBL] [Abstract][Full Text] [Related]
4. The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier.
Tetsuka K; Takanaga H; Ohtsuki S; Hosoya K; Terasaki T
J Neurochem; 2003 Nov; 87(4):891-901. PubMed ID: 14622120
[TBL] [Abstract][Full Text] [Related]
5. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
[TBL] [Abstract][Full Text] [Related]
6. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.
Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T
J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501
[TBL] [Abstract][Full Text] [Related]
7. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
Akanuma SI
Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
[TBL] [Abstract][Full Text] [Related]
8. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier transporters and response to CNS-active drugs.
Urquhart BL; Kim RB
Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
[TBL] [Abstract][Full Text] [Related]
10. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
11. Sodium and chloride-dependent high and low-affinity uptakes of GABA by brain capillary endothelial cells.
Zhang Y; Liu GQ
Brain Res; 1998 Oct; 808(1):1-7. PubMed ID: 9795097
[TBL] [Abstract][Full Text] [Related]
12. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.
Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T
Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389
[TBL] [Abstract][Full Text] [Related]
13. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
14. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
Römermann K; Fedrowitz M; Hampel P; Kaczmarek E; Töllner K; Erker T; Sweet DH; Löscher W
Neuropharmacology; 2017 May; 117():182-194. PubMed ID: 28192112
[TBL] [Abstract][Full Text] [Related]
15. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
16. [Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier].
Terasaki T
Yakugaku Zasshi; 2021; 141(4):447-462. PubMed ID: 33790111
[TBL] [Abstract][Full Text] [Related]
17. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
Ohtsuki S; Terasaki T
Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
[TBL] [Abstract][Full Text] [Related]
18. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier.
Kakee A; Takanaga H; Terasaki T; Naito M; Tsuruo T; Sugiyama Y
J Neurochem; 2001 Oct; 79(1):110-8. PubMed ID: 11595763
[TBL] [Abstract][Full Text] [Related]
19. Transporter-mediated permeation of drugs across the blood-brain barrier.
Tamai I; Tsuji A
J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
[TBL] [Abstract][Full Text] [Related]
20. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells.
Hino T; Yokota T; Ito S; Nishina K; Kang YS; Mori S; Hori S; Kanda T; Terasaki T; Mizusawa H
Biochem Biophys Res Commun; 2006 Feb; 340(1):263-7. PubMed ID: 16364250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
